A paradigm shift in post-bronchiolitis recurrent wheezing: the dual impact of COVID-19 and Nirsevimab - Amsterdam 2025

Infection, inflammation and innovation: new frontiers in paediatric respiratory health

Chair(s): Nadine Freitag, Stefan Unger

Session type: Oral presentation

A paradigm shift in post-bronchiolitis recurrent wheezing: the dual impact of COVID-19 and Nirsevimab

Maria Teresa Romero Rubio

EVENTS HOME

Previous presentation

Next presentation

Session content

Primary ciliary dyskinesia (PCD) patients with variants in dynein arm assembly factor genes may present with normal functional tests: a diagnostic challenge resolved by air-liquid interface (ALI) culture.

Janice Coles

Poster

Abstract

Slides

Comparison of Lower Airway Sampling Strategies in Children with Protracted Bacterial Bronchitis (CLASSIC-PBB)

Francis Gilchrist

Abstract

Slides

Genomic epidemiology of the macrolide resistant Mycoplasma pneumoniae outbreak in China, 2023

Chao Yan

Poster

Abstract

Slides

Epigenetic signatures of severe RSV infection in infants: evidence from non-invasive saliva samples

Sara Pischedda

Poster

Abstract

Slides

A paradigm shift in post-bronchiolitis recurrent wheezing: the dual impact of COVID-19 and Nirsevimab

Maria Teresa Romero Rubio

Poster

Abstract

Slides

A novel antiviral treatment that eliminates human metapneumovirus in human airway epithelial cells

Ivana Daniels

Poster

Abstract

Slides

Severe Mycoplasma pneumoniae Pneumonia and Mental Health Disorders in Adolescents: A Population-Matched Cohort Study With 18-Year Follow-Up From Birth

Eun Kyo Ha

Poster

Abstract

Slides

Acute Respiratory Infection Control Program: A case from Nepal

Prabin Shrestha

Poster

Abstract

Prophylactic Antibiotics to prevent chest infections in children with neurological impairment (PARROT): A randomised controlled trial

Paul Mcnamara

Poster

Abstract

Discussion and Q&A

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}